CURX — Curanex Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $12.87m
- $7.04m
Annual cashflow statement for Curanex Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.02 | -0.019 | -0.362 |
| Non-Cash Items | 0.021 | 0.002 | 0.075 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.002 | 0.017 | -0.269 |
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | 0.003 | -0 | -0.556 |
| Financing Cash Flow Items | -0.003 | 0.072 | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | -0.003 | 0.072 | 0.63 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.072 | 0.075 |